Loss of Taste and Smell as Distinguishing Symptoms of Coronavirus Disease 2019.

Ageusia COVID-19 Humans Olfaction Disorders SARS-CoV-2 Smell Taste
COVID-19 SARS-CoV-2 olfactory disorders taste disorders

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
16 02 2021
Historique:
received: 21 05 2020
accepted: 18 06 2020
pubmed: 21 6 2020
medline: 20 2 2021
entrez: 21 6 2020
Statut: ppublish

Résumé

In a household study, loss of taste and/or smell was the fourth most reported symptom (26/42 [62%]) among coronavirus disease 2019 (COVID-19) case patients and had the highest positive predictive value (83% [95% confidence interval [CI], 55%-95%) among household contacts. Olfactory and taste dysfunctions should be considered for COVID-19 case identification and testing prioritization.

Identifiants

DOI: 10.1093/cid/ciaa799 PMID: 32562541 PMC: PMC7337666
pubmed: 32562541
pii: 5860440
doi: 10.1093/cid/ciaa799
pmc: PMC7337666
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

682-685

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Auteurs

Patrick Dawson (P)

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Elizabeth M Rabold (EM)

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Rebecca L Laws (RL)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Erin E Conners (EE)

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Radhika Gharpure (R)

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sherry Yin (S)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sean A Buono (SA)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Trivikram Dasu (T)

City of Milwaukee Health Department Laboratory, Milwaukee, Wisconsin, USA.

Sanjib Bhattacharyya (S)

City of Milwaukee Health Department Laboratory, Milwaukee, Wisconsin, USA.

Ryan P Westergaard (RP)

Wisconsin Department of Health Services, Madison, Wisconsin, USA.

Ian W Pray (IW)

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Wisconsin Department of Health Services, Madison, Wisconsin, USA.

Dongni Ye (D)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.

Scott A Nabity (SA)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jacqueline E Tate (JE)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Hannah L Kirking (HL)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Troubles sensitifs › Troubles du goût › Agueusie › Loss of Taste and Smell as Distinguishing...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Loss of Taste and Smell as Distinguishing...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Loss of Taste and Smell as Distinguishing...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Troubles sensitifs › Troubles de l'olfaction › Loss of Taste and Smell as Distinguishing...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Loss of Taste and Smell as Distinguishing...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Sensation › Odorat › Loss of Taste and Smell as Distinguishing...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Sensation › Goût › Loss of Taste and Smell as Distinguishing...